Radiopharm Theranostics Limited (ASX:RAD)
Australia · Delayed Price · Currency is AUD 0.0040
0.00 (0.00%)
Oct 21, 2026, 3:58 PM AEST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of 19.52 million as of October 21, 2026. It is the 40,378th most valuable company in the world and the 1,130th biggest in Australia. Its market cap has decreased by 77.69% in one year.
Market Cap
19.52M
Enterprise Value
13.02M
Revenue
12.87M
Global Rank
Country Rank
#1,130 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from 101.33M to 19.52M, a decrease of -80.74%. That is a compound annual growth rate of -28.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 17.35M | -80.42% |
| Dec 31, 2025 | 88.61M | 68.31% |
| Dec 31, 2024 | 52.65M | 91.43% |
| Dec 29, 2023 | 27.50M | -20.28% |
| Dec 30, 2022 | 34.50M | -65.53% |
| Dec 31, 2021 | 100.07M | -1.25% |
| Nov 25, 2021 | 101.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nexsen | 26.03M |
| NeuroScientific Biopharmaceuticals | 23.38M |
| Algorae Pharmaceuticals | 20.28M |
| Proteomics International Laboratories | 19.02M |
| Imugene | 18.12M |
| Patrys | 16.30M |
| Argenica Therapeutics | 15.41M |
| Noxopharm | 15.36M |